908 Devices Inc. (MASS) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MASS Revenue Growth
Revenue Breakdown (FY 2025)
MASS's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
MASS Revenue Analysis (2018–2025)
As of May 9, 2026, 908 Devices Inc. (MASS) generated trailing twelve-month (TTM) revenue of $57.8 million, reflecting strong growth of +13.6% year-over-year. The most recent quarter (Q1 2026) recorded $13.4 million in revenue, down 23.0% sequentially.
Looking at the longer-term picture, MASS's 5-year compound annual growth rate (CAGR) stands at +15.9%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $59.6 million in 2024.
Revenue diversification analysis shows MASS's business is primarily driven by Device Sales (58%), Recurring (31%), and Product and service revenue (11%). With over half of revenue concentrated in Device Sales, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including MASI (-14.4% YoY), WAT (+26.4% YoY), and A (+8.1% YoY), MASS has underperformed the peer group in terms of revenue growth. Compare MASS vs MASI →
MASS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MASSCurrent | $58M | +13.6% | +15.9% | -70.1% | |
 MASI | $1.5B | -14.4% | +5.9% | 20.5% | |
 WAT | $3.2B | +26.4% | +6.0% | 28.2% | |
 A | $6.9B | +8.1% | +5.4% | 21.3% | |
 TMO | $44.6B | +5.4% | +6.7% | 18.2% | |
 BRKR | $3.4B | +0.4% | +11.6% | 6.9% |
MASS Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $56.2M | -5.8% | $28.4M | 50.6% | $-39,418,000 | -70.1% |
| 2024 | $59.6M | +18.7% | $29.9M | 50.2% | $-76,718,000 | -128.7% |
| 2023 | $50.2M | +7.2% | $25.3M | 50.4% | $-42,758,000 | -85.1% |
| 2022 | $46.9M | +11.0% | $26.0M | 55.5% | $-35,382,000 | -75.5% |
| 2021 | $42.2M | +56.9% | $23.2M | 55.0% | $-22,069,000 | -52.3% |
| 2020 | $26.9M | +49.6% | $14.9M | 55.5% | $-5,815,000 | -21.6% |
| 2019 | $18.0M | -18.5% | $8.1M | 45.3% | $-12,144,000 | -67.6% |
| 2018 | $22.1M | - | $12.4M | 56.2% | $-6,439,000 | -29.2% |
See MASS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MASS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MASS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMASS — Frequently Asked Questions
Quick answers to the most common questions about buying MASS stock.
Is MASS's revenue growth accelerating or slowing?
MASS maintains +13.6% revenue growth, in line with its 5-year CAGR of +15.9%. TTM revenue stands at $58M. Growth rate remains consistent with historical average.
What is MASS's long-term revenue growth rate?
908 Devices Inc.'s 5-year revenue CAGR of +15.9% reflects the sustained expansion pattern. Current YoY growth of +13.6% is near this long-term average.
How is MASS's revenue distributed by segment?
MASS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.